Beyond Diagnostics is a Swiss deep-tech company developing point-of-care tests for medication quality, starting with insulin.
Beyond Diagnostics AG has raised $139K in total funding. The most recent round was Grant. The last funding was announced in April 2026.
Beyond Diagnostics AG's investors include DCB, Venture Kick, Innosuisse, DayOne accelerator, BernInvest.
Beyond Diagnostics AG is headquartered in Bern, Switzerland.
Beyond Diagnostics is a Swiss deep-tech company developing point-of-care tests for medication quality, starting with insulin.
Beyond Diagnostics AG is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Beyond Diagnostics AG — Funding & Investors." VCBacked, April 1, 2026, https://www.vcbacked.co/company/beyond-diagnostics-ag. Accessed September 30, 2026.
VCBacked. (2026). Beyond Diagnostics AG — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/beyond-diagnostics-ag
{{cite web |title=Beyond Diagnostics AG — Funding & Investors |url=https://www.vcbacked.co/company/beyond-diagnostics-ag |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated